Are Illumina’s 2019 Challenges Transitory?

Illumina Stock Dropped Following Their Preliminary Revenue Announcement
Illumina (ILMN) stock dropped 16% following the firm's announcement of preliminary revenue for the second quarter of the fiscal year 2019 and updated its 2019 revenue guidance.

According to the firm’s press release its second quarter results were impacted by an approximately $30 million lower revenue than expected; associated with population genomics initiatives, including a sizeable sequencing . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.